Editorial: Immunoglobulin Therapy in the 21st Century – the Dark Side of the Moon


Since its widespread introduction in the early 1980s, immunoglobulin therapy (IG) has been extensively investigated to understand its mechanism of action and clinical benefits. Research has also continued to improve its production. The survival benefits of IG for patients with primary immunodeficiency (PID) are accepted (1). The basic principle of replacing… (More)
DOI: 10.3389/fimmu.2015.00436


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics